| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/20/1992 | WO1992013568A1 Vp6 encapsulated drug delivery |
| 08/20/1992 | WO1992013567A1 Biodegradable polymer blends for drug delivery |
| 08/20/1992 | WO1992013566A1 Interpenetrating-polymer network phase-transition gels |
| 08/20/1992 | WO1992013565A1 Growth factor containing matrix for the treatment of cartilage lesions |
| 08/20/1992 | WO1992013562A1 An immunotoxin with in vivo t cell suppressant activity |
| 08/20/1992 | WO1992013561A1 Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis |
| 08/20/1992 | WO1992013547A1 Drug delivery composition and method of using the same |
| 08/20/1992 | WO1992013533A1 Pharmaceutical compositions containing amethocaine |
| 08/20/1992 | WO1992013527A1 Water-dispersible tablets |
| 08/20/1992 | WO1992013526A1 Stabilisation of fibroblast growth factor using a polysaccharide |
| 08/20/1992 | WO1992013525A1 Synthetic membrane vesicles containing functionally active fusion peptides as drug delivery systems |
| 08/20/1992 | WO1992004916A3 Particulate agents |
| 08/20/1992 | DE4136930A1 Verfahren zur herstellung einer pharmazeutischen zusammensetzung, die pharmazeutische zusammensetzung sowie deren verwendung A process for preparing a pharmaceutical composition, the pharmaceutical composition and the use thereof |
| 08/20/1992 | CA2101773A1 Interpenetrating-polymer network phase-transition gels |
| 08/20/1992 | CA2101735A1 Vp6 encapsulated drug delivery |
| 08/20/1992 | CA2058263A1 Pharmaceutical formulations |
| 08/19/1992 | EP0499399A1 Analgesic compositions |
| 08/19/1992 | EP0499322A1 (Carboxyl)alkyloxyalkyl derivatives of cyclodextrins |
| 08/19/1992 | EP0499299A2 Surface modified drug nanoparticles |
| 08/19/1992 | CN1063698A Polymer base blend compositions containing destructurized starch |
| 08/19/1992 | CN1063615A Radiopharmaceutical formulations, their method of administration and process of preparation |
| 08/19/1992 | CN1017867B Method of preparing covaluently-modified neutral bacterial poly-saccharides and thereof covalent conjugates of such polysaccharides and immunogenic protein |
| 08/18/1992 | US5140104 Reacting free carboxyl of N-protected, carboxyl-protected glutamic acid with reactive amine, removing N-protecting group, reacting with activated carboxyl group of folic acid derivative, removing all protecting groups |
| 08/18/1992 | US5140043 Using 1:1 ratio of acid to water and pH of no more than 3.5; sunblock compositions |
| 08/18/1992 | US5140013 Shelf life; polymerization inhibition; nontoxic; side effects reduction |
| 08/18/1992 | US5140010 Stabilized aqueous formulations of thymopentin |
| 08/18/1992 | US5139740 Polyprenyl compound composition for soft capsules |
| 08/18/1992 | US5139687 Inclusion complex suspended in a mixture of polyalkylene glycol carrier and a polar solvent |
| 08/18/1992 | CA1306414C Affinity enhancement system |
| 08/16/1992 | WO1992014762A1 (carboxyl)alkyloxyalkyl derivatives of cyclodextrins |
| 08/16/1992 | CA2104097A1 (carboxyl)alkyloxyalkyl derivatives of cyclodextrins |
| 08/13/1992 | DE4104186A1 Neue, ueber endozytose in hoehere eukaryotische zellen aufnehmbare, nukleinsaeure enthaltende komplexe New, via endocytosis in higher eukaryotic cells recordable nucleic acid-containing complex |
| 08/13/1992 | DE4103681A1 Derivate von disaccharidalkoholen, verfahren zu ihrer herstellung und ihre verwendung Disaccharide derivatives, process for their production and their use |
| 08/12/1992 | WO1992013531A1 Nutritional supplement containing vitamin e |
| 08/12/1992 | EP0498729A1 Dipeptide derivatives with urethan groupings, their preparation and their application, especially as hydratating agents and tensioactive agents in cosmetic, pharmaceutical and alimentary preparations |
| 08/12/1992 | EP0498658A2 Composition for inducing humoral anergy to an immunogen |
| 08/12/1992 | EP0498471A2 Liposomes comprising a guanidino aminoglycoside |
| 08/12/1992 | EP0498470A2 An injectable pharmaceutical composition for the protection of tissue damaged by ischemia |
| 08/12/1992 | EP0498372A1 Sustained-release pranoprofen preparation |
| 08/12/1992 | EP0497997A1 Synthetic membrane vesicles containing functionally active fusion peptides as drug delivery systems |
| 08/12/1992 | EP0497846A1 Drug delivery system, method for preparing the same, and use thereof. |
| 08/12/1992 | EP0375689B1 A pharmaceutical composition adapted for transdermal delivery of an opoid drug. |
| 08/11/1992 | US5138045 Polyamine conjugated oligonucleotides |
| 08/11/1992 | US5138043 Stability; mildness to skin |
| 08/11/1992 | US5137877 Bifunctional linking compounds, conjugates and methods for their production |
| 08/11/1992 | US5137733 Controlled release pharmaceutical preparation |
| 08/11/1992 | US5137730 Tablet composition and method for problem pharmaceutical materials using citric acid |
| 08/11/1992 | US5137718 Infection fighting composition for topical application |
| 08/11/1992 | CA1306196C Pharmaceutical composition containing a benzol urea |
| 08/11/1992 | CA1306194C Use of amphipathic molecules for radio-imaging and therapy with conjugates of monoclonal or polyclonal antibodies |
| 08/11/1992 | CA1306192C Medicament containing a silicon derivative of menthol |
| 08/09/1992 | WO1992013558A1 A composition for inducing humoral anergy |
| 08/09/1992 | CA2060493A1 Sustained-release pranoprofen preparation |
| 08/07/1992 | CA2060605A1 Urethan group dipeptide derivatives; process for preparing the same and their use, especially as hydrating agents and surfactants in cosmetic, pharmaceutical or food products |
| 08/06/1992 | WO1992013095A1 Methods for treating tumor necrosis factor mediated diseases |
| 08/06/1992 | WO1992013072A2 Process for the synthesis and purification of human ciliary neuronotrophic factor (cntf) from escherichia coli |
| 08/06/1992 | WO1992013006A1 Polyose and fatty acid complex with high fatty acid content, use as emulsifying or moisturizing agent, and emulsifying or moisturizing composition containing it |
| 08/06/1992 | WO1992012995A1 Process for coupling carbohydrates to substrates |
| 08/06/1992 | WO1992012739A1 Depot formulations |
| 08/06/1992 | WO1992012735A1 Composition containing ultrafine particles of magnetic metal oxide |
| 08/06/1992 | WO1992012730A1 A method and a system for enhanced in vivo clearance of diagnostic and/or therapeutic agents by extracorporeal depletion, and the use of said agents for said purpose |
| 08/06/1992 | WO1992012710A1 Orally administerable drugs for the treatment of central dopamine deficiency conditions |
| 08/06/1992 | WO1992011037A3 Targeting of therapeutic agents using polysaccharides |
| 08/06/1992 | DE4103360A1 Use of acetyl-cysteine and isotonic sodium chloride (0.9 per cent) - for treating bronchial asthma and bronchitis-induced spasms |
| 08/05/1992 | EP0497525A2 Pneumococcal polysaccharide conjugate vaccine |
| 08/05/1992 | EP0497353A2 Oral antibacterial compositions and method for the improvement of gastrointestinal absorption of penem or carbapenem antibiotics |
| 08/05/1992 | EP0497331A2 Process for the preparation of tablets or film-coated tablets |
| 08/05/1992 | EP0497240A1 Preparation for controlled release of drugs for ruminants |
| 08/05/1992 | EP0497162A1 Pharmaceutical compositions containing orally absorbable glycosaminoglycans |
| 08/05/1992 | EP0496819A1 Direct compression carrier composition |
| 08/05/1992 | EP0348431B1 Liposome-incorporated nystatin |
| 08/05/1992 | EP0261213B1 Formulation for preparing sustained release drugs for oral administration |
| 08/05/1992 | EP0248885B1 Transdermal delivery of drugs |
| 08/05/1992 | CN1063221A Polyamine drug-resin complexes |
| 08/04/1992 | US5135919 Method and a pharmaceutical composition for the inhibition of angiogenesis |
| 08/04/1992 | US5135866 Very low protein nutrient medium for cell culture |
| 08/04/1992 | US5135736 Covalently-linked complexes and methods for enhanced cytotoxicity and imaging |
| 08/02/1992 | WO1992013569A1 Targeted polymeric conjugates of cyclosporin and method for their preparation |
| 08/02/1992 | CA2079590A1 Targeted polymeric conjugates of cyclosporin and method for their preparation |
| 07/30/1992 | DE4101873A1 Peroral applizierbare arzneiform zur behandlung zentraler dopaminmangelzustaende Orally administered drug form for treatment central dopaminmangelzustaende |
| 07/30/1992 | CA2035143A1 Compositions with enhanced penetration |
| 07/29/1992 | EP0496705A1 Composition especially adapted for encapsulation in a solid shell and process for preparing same |
| 07/29/1992 | EP0496579A2 Modified immunogens comprising an immunogen attached to one or more non-immunogenic polymers |
| 07/29/1992 | EP0496437A2 Use of specific core material and layers to obtain pharmaceutical formulations stable to discolouration of omeprazole |
| 07/29/1992 | EP0496074A1 Biotinylated monoclonal antibodies, avidin and biotin for diagnosis and therapy |
| 07/29/1992 | EP0346501B1 Pharmaceutical preparation for treating immunodeficiency conditions |
| 07/29/1992 | CN1063039A Solid dosage of almokalant and processes for manufacture thereof |
| 07/29/1992 | CA2060066A1 Preparation for the sustained release of active substances which are suitable as a therapeutic system or for improving growth and feed utilization in ruminants |
| 07/28/1992 | US5134127 Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
| 07/28/1992 | US5134122 Salts of peptides, sustained release |
| 07/28/1992 | US5134071 Polymerization and copolymerization of proteins |
| 07/28/1992 | US5133979 Glycoprotein and complex carbohydrates |
| 07/28/1992 | US5133973 Pharmaceutical preparations |
| 07/28/1992 | CA1305724C Calcium lactate-glycerol adduct, a process for its preparation and itsuse |
| 07/28/1992 | CA1305670C Stable and quick-breaking topical skin compositions |
| 07/28/1992 | CA1305668C Multivitamin preparation |
| 07/28/1992 | CA1305665C Macromolecular platinum antitumor compounds |
| 07/26/1992 | WO1992012704A1 Method for masking the taste of a medicament |
| 07/26/1992 | CA2077658A1 Method for masking the taste of a medicament |
| 07/25/1992 | WO1992012729A1 Monoclonal antibodies to elam-1 and their uses |